David A Fellows insider trades: Nightstar Therapeutics (NITE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 1, 2019 | NITE | ↓ Sell | 9,305 | $25.31 | $236K | Direct | Apr 3, 2019 (2d) |
| Jan 7, 2019 | NITE | ↓ Sell | 8,733 | $12.98 | $113K | Direct | Jan 9, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David A Fellows's insider trades
David A Fellows is Chief Executive Officer at Nightstar Therapeutics (NITE). Since Jan 7, 2019, David has reported no open-market purchases and 2 sales worth $349K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NITE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.